Rs 1,960 Calls on Sun Pharmaceutical Industries Ltd See Heavy Activity — What the Strike Price Tells You

Options Event and Cash Market Price Action

The call options expiring on 29 Sep 2026 saw significant turnover, with 4,834 contracts traded at the Rs 1,960 strike and 5,265 contracts at the Rs 1,940 strike. The Rs 1,940 strike, slightly out-of-the-money given the stock's close at Rs 1,936.50, recorded the highest volume and turnover of ₹643.12 lakhs, compared to ₹438.20 lakhs at Rs 1,960. Open interest at these strikes stood at 2,786 and 3,564 contracts respectively, indicating a substantial base of existing positions. The proximity of these strikes to the current price suggests that market participants are positioning for a near-term directional move rather than a distant speculative bet — is this a sign of confidence in the stock’s immediate momentum or a hedge against volatility?

Strike Price and Moneyness Analysis

The Rs 1,960 strike is just Rs 23.50 above the underlying price, placing it slightly out-of-the-money but close enough to be sensitive to small price movements. Meanwhile, the Rs 1,940 strike is effectively at-the-money, with the stock trading just below it. At-the-money calls are the most responsive to directional shifts, reflecting a bet on imminent price changes rather than long-term targets. The concentration of volume at these strikes reveals a preference for immediate upside exposure, with the Rs 1,940 strike likely representing the most gamma-sensitive position. This suggests traders are anticipating a move that could push the stock above this level before expiry — how does this align with recent price momentum and technical signals?

Open Interest and Contracts-Traded Analysis

Open interest at Rs 1,940 stands at 3,564 contracts, while 5,265 contracts traded on the day, yielding a contracts-to-OI ratio of approximately 1.48:1. This elevated ratio indicates a significant influx of fresh positions rather than mere rotation of existing holdings. Similarly, the Rs 1,960 strike shows a ratio of about 1.73:1, reinforcing the view of new money entering the call options market. High turnover combined with robust open interest suggests that the options market is actively building directional exposure ahead of the expiry. The sizeable open interest also implies that these strikes are key levels for market participants, potentially serving as focal points for price action in the coming weeks.

Cash Market Context: Price Momentum and Moving Averages

Sun Pharmaceutical Industries Ltd has outperformed its sector by 0.65% on the day, gaining 0.47% while the Sensex declined 0.90%. The stock has traded within a narrow range of Rs 1, with its closing price at Rs 1,936.50. Notably, it is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, signalling a sustained upward trend. This technical backdrop supports the directional call activity, as the options market appears to be echoing the positive momentum in the cash market — does this alignment strengthen the case for continuation or is the rally nearing a pause?

Delivery Volume and Liquidity Considerations

Delivery volumes on 1 Sep rose sharply to 20.11 lakh shares, a 100.18% increase over the 5-day average, indicating strong investor participation in the cash market. This surge in delivery volume confirms that the call options activity is not occurring in isolation but is supported by genuine buying interest in the underlying shares. The stock’s liquidity, with a trade size capacity of approximately ₹7.66 crore based on 2% of the 5-day average traded value, ensures that both cash and derivatives markets can absorb sizeable trades without undue price impact. This congruence between delivery volumes and call option activity suggests a coherent directional stance across market segments.

Key Data at a Glance

Interpreting the Options and Cash Market Signals

The concentration of call contracts near the current price, combined with elevated open interest and turnover, points to a deliberate directional positioning in Sun Pharmaceutical Industries Ltd. The near-the-money strikes suggest traders are betting on a price move in the short term, consistent with the 29 Sep expiry. The contracts-to-OI ratios above 1.4 at both strikes indicate fresh money entering the market rather than mere position reshuffling. This is reinforced by the stock’s steady gains and its position above key moving averages, which provide technical support for the bullish stance. The doubling of delivery volumes further confirms that the cash market is participating actively, lending credibility to the options market’s directional signals — should this combined momentum prompt a reassessment of the stock’s near-term outlook?

Conclusion: What the Call Activity Reveals

The heavy call option activity at strikes closely aligned with the underlying price, coupled with strong open interest and rising delivery volumes, suggests a concerted directional bet on Sun Pharmaceutical Industries Ltd. The options market is signalling confidence in a near-term upward move, supported by the stock’s technical positioning above multiple moving averages and active participation in the cash market. While the expiry is still nearly four weeks away, the volume and turnover patterns indicate urgency in establishing these positions. The interplay between fresh call buying and sustained delivery volumes paints a picture of alignment between derivatives and cash markets — buy, sell, or hold Sun Pharma? The multi-factor analysis resolves the contradiction.

Get 33% Off on our 1 Year Plan - Limited Period Only! Start Today